Category:Neoplastic gene expression regulation

Media in category "Neoplastic gene expression regulation"

The following 108 files are in this category, out of 108 total.

8p22-MTUS1-Gene-Product-ATIP3-Is-a-Novel-Anti-Mitotic-Protein-Underexpressed-in-Invasive-Breast-pone.0007239.s006.ogv 29 s, 220 × 220; 1.41 MB
8p22-MTUS1-Gene-Product-ATIP3-Is-a-Novel-Anti-Mitotic-Protein-Underexpressed-in-Invasive-Breast-pone.0007239.s007.ogv 21 s, 220 × 220; 549 KB
A-Comprehensive-Panel-of-Three-Dimensional-Models-for-Studies-of-Prostate-Cancer-Growth-Invasion-pone.0010431.s013.ogv 1 min 6 s, 524 × 384; 8.71 MB
A-Cryptic-Frizzled-Module-in-Cell-Surface-Collagen-18-Inhibits-Wntβ−Catenin-Signaling-pone.0001878.s005.ogv 2.3 s, 1,024 × 1,024; 130 KB
A-Cryptic-Frizzled-Module-in-Cell-Surface-Collagen-18-Inhibits-Wntβ−Catenin-Signaling-pone.0001878.s006.ogv 2.0 s, 450 × 338; 77 KB
A-Gene-Expression-Signature-of-Invasive-Potential-in-Metastatic-Melanoma-Cells-pone.0008461.s008.ogv 15 s, 640 × 480; 2.11 MB
A-Gene-Expression-Signature-of-Invasive-Potential-in-Metastatic-Melanoma-Cells-pone.0008461.s009.ogv 15 s, 640 × 480; 2.37 MB
A-Membrane-Type-1-Matrix-Metalloproteinase-(MT1-MMP)-–-Discoidin-Domain-Receptor-1-Axis-Regulates-pone.0116006.s021.ogv 49 s, 720 × 480; 1.91 MB
A-Membrane-Type-1-Matrix-Metalloproteinase-(MT1-MMP)-–-Discoidin-Domain-Receptor-1-Axis-Regulates-pone.0116006.s022.ogv 49 s, 720 × 480; 1.89 MB
A-New-Paradigm-for-MAPK-Structural-Interactions-of-hERK1-with-Mitochondria-in-HeLa-Cells-pone.0007541.s014.ogv 20 s, 512 × 512; 155 KB
A-New-Paradigm-for-MAPK-Structural-Interactions-of-hERK1-with-Mitochondria-in-HeLa-Cells-pone.0007541.s015.ogv 10 s, 512 × 512; 148 KB
A-novel-patient-derived-intra-femoral-xenograft-model-of-bone-metastatic-prostate-cancer-that-1479-5876-9-185-S1.ogv 46 s, 1,280 × 720; 3.8 MB
A-novel-patient-derived-intra-femoral-xenograft-model-of-bone-metastatic-prostate-cancer-that-1479-5876-9-185-S2.ogv 26 s, 1,280 × 720; 3.46 MB
A-Novel-Role-for-WntCa2+-Signaling-in-Actin-Cytoskeleton-Remodeling-and-Cell-Motility-in-Prostate-pone.0010456.s013.ogv 6.0 s, 1,026 × 512; 19.14 MB
A-Novel-Role-for-WntCa2+-Signaling-in-Actin-Cytoskeleton-Remodeling-and-Cell-Motility-in-Prostate-pone.0010456.s014.ogv 29 s, 1,152 × 924; 9.57 MB
A-Novel-Role-for-WntCa2+-Signaling-in-Actin-Cytoskeleton-Remodeling-and-Cell-Motility-in-Prostate-pone.0010456.s015.ogv 28 s, 1,152 × 924; 6.55 MB
Cell-movement-pbio.1001320.s011.ogv 8.4 s, 512 × 512; 106 KB
Cell-movement-pbio.1001320.s012.ogv 25 s, 1,060 × 793; 123 KB
Cell-movement-pbio.1001320.s013.ogv 24 s, 786 × 576; 2.16 MB
Characterization-of-AKT-independent-effects-of-the-synthetic-AKT-inhibitors-SH-5-and-SH-6-using-an-1471-2407-10-287-S3.ogv 21 s, 210 × 214; 1.17 MB
Characterization-of-AKT-independent-effects-of-the-synthetic-AKT-inhibitors-SH-5-and-SH-6-using-an-1471-2407-10-287-S4.ogv 28 s, 210 × 214; 663 KB
Characterization-of-AKT-independent-effects-of-the-synthetic-AKT-inhibitors-SH-5-and-SH-6-using-an-1471-2407-10-287-S5.ogv 28 s, 210 × 214; 676 KB
Characterization-of-AKT-independent-effects-of-the-synthetic-AKT-inhibitors-SH-5-and-SH-6-using-an-1471-2407-10-287-S6.ogv 28 s, 210 × 214; 855 KB
Chronic-stress-in-mice-remodels-lymph-vasculature-to-promote-tumour-cell-dissemination-ncomms10634-s2.ogv 5.4 s, 1,255 × 760; 3.76 MB
Chronic-stress-in-mice-remodels-lymph-vasculature-to-promote-tumour-cell-dissemination-ncomms10634-s3.ogv 24 s, 1,280 × 720; 8.95 MB
Clusterin-facilitates-stress-induced-lipidation-of-LC3-and-autophagosome-biogenesis-to-enhance-ncomms6775-s2.ogv 3.8 s, 303 × 296; 70 KB
Correlation-analysis-of-two-dimensional-gel-electrophoretic-protein-patterns-and-biological-1471-2105-7-198-S1.ogv 48 s, 800 × 600; 7.85 MB
Fibronectin-Matrix-Assembly-Suppresses-Dispersal-of-Glioblastoma-Cells-pone.0024810.s004.ogv 18 s, 960 × 540; 1.06 MB
Fibronectin-Matrix-Assembly-Suppresses-Dispersal-of-Glioblastoma-Cells-pone.0024810.s005.ogv 18 s, 960 × 540; 1.73 MB
Functional-characterization-of-E--and-P-cadherin-in-invasive-breast-cancer-cells-1471-2407-9-74-S1.ogv 7.7 s, 512 × 512; 5.01 MB
Functional-characterization-of-E--and-P-cadherin-in-invasive-breast-cancer-cells-1471-2407-9-74-S2.ogv 8.3 s, 512 × 512; 5.53 MB
Functional-characterization-of-E--and-P-cadherin-in-invasive-breast-cancer-cells-1471-2407-9-74-S3.ogv 7.7 s, 512 × 512; 2.76 MB
Genome-Wide-Screening-Identified-That-miR-134-Acts-as-a-Metastasis-Suppressor-by-Targeting-Integrin-pone.0087665.s006.ogv 4.6 s, 625 × 480; 1.69 MB
Genome-Wide-Screening-Identified-That-miR-134-Acts-as-a-Metastasis-Suppressor-by-Targeting-Integrin-pone.0087665.s007.ogv 4.6 s, 625 × 480; 1.72 MB
Genome-Wide-Screening-Identified-That-miR-134-Acts-as-a-Metastasis-Suppressor-by-Targeting-Integrin-pone.0087665.s008.ogv 4.8 s, 625 × 480; 2.3 MB
Hypoxia-regulates-global-membrane-protein-endocytosis-through-caveolin-1-in-cancer-cells-ncomms11371-s5.ogv 45 s, 242 × 240; 8.29 MB
Hypoxia-regulates-global-membrane-protein-endocytosis-through-caveolin-1-in-cancer-cells-ncomms11371-s6.ogv 4.0 s, 240 × 240; 48 KB
Hypoxia-regulates-global-membrane-protein-endocytosis-through-caveolin-1-in-cancer-cells-ncomms11371-s7.ogv 4.0 s, 240 × 240; 75 KB
Identification-of-pyrazolopyridazinones-as-PDEδ-inhibitors-ncomms11360-s1.ogv 9.0 s, 671 × 512; 2.61 MB
Identification-of-pyrazolopyridazinones-as-PDEδ-inhibitors-ncomms11360-s2.ogv 9.0 s, 671 × 512; 2.91 MB
Identification-of-pyrazolopyridazinones-as-PDEδ-inhibitors-ncomms11360-s3.ogv 9.0 s, 671 × 512; 3.52 MB
Identification-of-pyrazolopyridazinones-as-PDEδ-inhibitors-ncomms11360-s4.ogv 9.0 s, 671 × 512; 3.27 MB
Identification-of-pyrazolopyridazinones-as-PDEδ-inhibitors-ncomms11360-s5.ogv 9.0 s, 671 × 512; 4.61 MB
Identification-of-pyrazolopyridazinones-as-PDEδ-inhibitors-ncomms11360-s6.ogv 9.0 s, 671 × 512; 2.34 MB
In-situ-protein-expression-in-tumour-spheres-development-of-an-immunostaining-protocol-for-confocal-1471-2407-10-106-S2.ogv 2.6 s, 2,164 × 1,024; 755 KB
In-vitro-discovery-of-promising-anti-cancer-drug-combinations-using-iterative-maximisation-of-a-srep14118-s5.ogv 12 s, 1,920 × 1,080; 3.29 MB
In-vitro-discovery-of-promising-anti-cancer-drug-combinations-using-iterative-maximisation-of-a-srep14118-s6.ogv 12 s, 1,920 × 1,080; 6.59 MB
In-vitro-discovery-of-promising-anti-cancer-drug-combinations-using-iterative-maximisation-of-a-srep14118-s7.ogv 12 s, 1,920 × 1,080; 3.44 MB
Inhibition-of-cathepsin-B-activity-attenuates-extracellular-matrix-degradation-and-inflammatory-bcr3058-S1.ogv 4.0 s, 576 × 576; 1,001 KB
Inhibition-of-cathepsin-B-activity-attenuates-extracellular-matrix-degradation-and-inflammatory-bcr3058-S2.ogv 4.6 s, 576 × 576; 901 KB
Inhibition-of-cathepsin-B-activity-attenuates-extracellular-matrix-degradation-and-inflammatory-bcr3058-S3.ogv 6.1 s, 512 × 512; 2.06 MB
Inhibition-of-cathepsin-B-activity-attenuates-extracellular-matrix-degradation-and-inflammatory-bcr3058-S4.ogv 6.1 s, 512 × 512; 2.08 MB
Interplay-between-arginine-methylation-and-ubiquitylation-regulates-KLF4-mediated-genome-stability-ncomms9419-s2.ogv 1 min 34 s, 448 × 350; 29.23 MB
Melanoma-cell-lysosome-secretory-burst-neutralizes-the-CTL-mediated-cytotoxicity-at-the-lytic-ncomms10823-s10.ogv 6.9 s, 320 × 240; 190 KB
Melanoma-cell-lysosome-secretory-burst-neutralizes-the-CTL-mediated-cytotoxicity-at-the-lytic-ncomms10823-s11.ogv 5.6 s, 320 × 240; 262 KB
Melanoma-cell-lysosome-secretory-burst-neutralizes-the-CTL-mediated-cytotoxicity-at-the-lytic-ncomms10823-s12.ogv 7.6 s, 320 × 240; 316 KB
Melanoma-cell-lysosome-secretory-burst-neutralizes-the-CTL-mediated-cytotoxicity-at-the-lytic-ncomms10823-s13.ogv 13 s, 320 × 240; 630 KB
Melanoma-cell-lysosome-secretory-burst-neutralizes-the-CTL-mediated-cytotoxicity-at-the-lytic-ncomms10823-s14.ogv 12 s, 320 × 240; 358 KB
Melanoma-cell-lysosome-secretory-burst-neutralizes-the-CTL-mediated-cytotoxicity-at-the-lytic-ncomms10823-s15.ogv 12 s, 320 × 240; 150 KB
Melanoma-cell-lysosome-secretory-burst-neutralizes-the-CTL-mediated-cytotoxicity-at-the-lytic-ncomms10823-s16.ogv 8.1 s, 320 × 240; 174 KB
Melanoma-cell-lysosome-secretory-burst-neutralizes-the-CTL-mediated-cytotoxicity-at-the-lytic-ncomms10823-s17.ogv 12 s, 320 × 240; 183 KB
Melanoma-cell-lysosome-secretory-burst-neutralizes-the-CTL-mediated-cytotoxicity-at-the-lytic-ncomms10823-s18.ogv 12 s, 320 × 240; 177 KB
Melanoma-cell-lysosome-secretory-burst-neutralizes-the-CTL-mediated-cytotoxicity-at-the-lytic-ncomms10823-s19.ogv 33 s, 320 × 240; 309 KB
Melanoma-cell-lysosome-secretory-burst-neutralizes-the-CTL-mediated-cytotoxicity-at-the-lytic-ncomms10823-s2.ogv 14 s, 320 × 240; 324 KB
Melanoma-cell-lysosome-secretory-burst-neutralizes-the-CTL-mediated-cytotoxicity-at-the-lytic-ncomms10823-s20.ogv 50 s, 320 × 240; 361 KB
Melanoma-cell-lysosome-secretory-burst-neutralizes-the-CTL-mediated-cytotoxicity-at-the-lytic-ncomms10823-s21.ogv 33 s, 320 × 240; 254 KB
Melanoma-cell-lysosome-secretory-burst-neutralizes-the-CTL-mediated-cytotoxicity-at-the-lytic-ncomms10823-s3.ogv 18 s, 320 × 240; 677 KB
Melanoma-cell-lysosome-secretory-burst-neutralizes-the-CTL-mediated-cytotoxicity-at-the-lytic-ncomms10823-s4.ogv 9.1 s, 320 × 240; 192 KB
Melanoma-cell-lysosome-secretory-burst-neutralizes-the-CTL-mediated-cytotoxicity-at-the-lytic-ncomms10823-s5.ogv 8.2 s, 320 × 240; 150 KB
Melanoma-cell-lysosome-secretory-burst-neutralizes-the-CTL-mediated-cytotoxicity-at-the-lytic-ncomms10823-s6.ogv 12 s, 320 × 240; 252 KB
Melanoma-cell-lysosome-secretory-burst-neutralizes-the-CTL-mediated-cytotoxicity-at-the-lytic-ncomms10823-s7.ogv 12 s, 320 × 240; 246 KB
Melanoma-cell-lysosome-secretory-burst-neutralizes-the-CTL-mediated-cytotoxicity-at-the-lytic-ncomms10823-s8.ogv 13 s, 320 × 240; 541 KB
Melanoma-cell-lysosome-secretory-burst-neutralizes-the-CTL-mediated-cytotoxicity-at-the-lytic-ncomms10823-s9.ogv 21 s, 320 × 240; 1,006 KB
Oblongifolin-C-inhibits-metastasis-by-up-regulating-keratin-18-and-tubulins-srep10293-s2.ogv 14 s, 1,365 × 1,024; 52.06 MB
Oblongifolin-C-inhibits-metastasis-by-up-regulating-keratin-18-and-tubulins-srep10293-s3.ogv 14 s, 1,365 × 1,024; 51.8 MB
P53-Target-Gene-SMAR1-Is-Dysregulated-in-Breast-Cancer-Its-Role-in-Cancer-Cell-Migration-and-pone.0000660.s007.ogv 14 s, 480 × 360; 4.48 MB
P53-Target-Gene-SMAR1-Is-Dysregulated-in-Breast-Cancer-Its-Role-in-Cancer-Cell-Migration-and-pone.0000660.s008.ogv 14 s, 480 × 360; 3.17 MB
P53-Target-Gene-SMAR1-Is-Dysregulated-in-Breast-Cancer-Its-Role-in-Cancer-Cell-Migration-and-pone.0000660.s009.ogv 14 s, 480 × 360; 3.53 MB
Role-of-thioredoxin-reductase-1-and-thioredoxin-interacting-protein-in-prognosis-of-breast-cancer-bcr2599-S6.ogv 1 min 12 s, 688 × 516; 18.27 MB
Sensitive-β-galactosidase-targeting-fluorescence-probe-for-visualizing-small-peritoneal-metastatic-ncomms7463-s2.ogv 15 s, 640 × 480; 1.05 MB
Sensitive-β-galactosidase-targeting-fluorescence-probe-for-visualizing-small-peritoneal-metastatic-ncomms7463-s3.ogv 29 s, 640 × 480; 2.22 MB
Ss3-integrin-modulates-transforming-growth-factor-beta-induced-(TGFBI)-function-and-paclitaxel-1476-4598-11-36-S5.ogv 20 s, 240 × 220; 531 KB
TGF-β1-induced-EMT-promotes-targeted-migration-of-breast-cancer-cells-through-the-lymphatic-system-onc2015133x6.ogv 10 s, 800 × 600; 998 KB
TGF-β1-induced-EMT-promotes-targeted-migration-of-breast-cancer-cells-through-the-lymphatic-system-onc2015133x7.ogv 10 s, 800 × 600; 430 KB
Thymosin-β10-Expression-Driven-by-the-Human-TERT-Promoter-Induces-Ovarian-Cancer-Specific-Apoptosis-pone.0035399.s001.ogv 26 s, 480 × 480; 4.58 MB
TIMP-2-Fusion-Protein-with-Human-Serum-Albumin-Potentiates-Anti-Angiogenesis-Mediated-Inhibition-of-pone.0035710.s006.ogv 23 s, 480 × 336; 1.61 MB
TIMP-2-Fusion-Protein-with-Human-Serum-Albumin-Potentiates-Anti-Angiogenesis-Mediated-Inhibition-of-pone.0035710.s007.ogv 7.3 s, 480 × 336; 408 KB
TRB3-links-insulinIGF-to-tumour-promotion-by-interacting-with-p62-and-impeding-ncomms8951-s10.ogv 6.0 s, 512 × 512; 193 KB
TRB3-links-insulinIGF-to-tumour-promotion-by-interacting-with-p62-and-impeding-ncomms8951-s2.ogv 6.0 s, 512 × 512; 121 KB
TRB3-links-insulinIGF-to-tumour-promotion-by-interacting-with-p62-and-impeding-ncomms8951-s3.ogv 6.0 s, 512 × 512; 166 KB
TRB3-links-insulinIGF-to-tumour-promotion-by-interacting-with-p62-and-impeding-ncomms8951-s4.ogv 6.0 s, 512 × 512; 177 KB
TRB3-links-insulinIGF-to-tumour-promotion-by-interacting-with-p62-and-impeding-ncomms8951-s5.ogv 6.0 s, 512 × 512; 292 KB
TRB3-links-insulinIGF-to-tumour-promotion-by-interacting-with-p62-and-impeding-ncomms8951-s6.ogv 6.0 s, 512 × 512; 181 KB
TRB3-links-insulinIGF-to-tumour-promotion-by-interacting-with-p62-and-impeding-ncomms8951-s7.ogv 6.0 s, 512 × 512; 191 KB
TRB3-links-insulinIGF-to-tumour-promotion-by-interacting-with-p62-and-impeding-ncomms8951-s8.ogv 8.0 s, 512 × 512; 285 KB
TRB3-links-insulinIGF-to-tumour-promotion-by-interacting-with-p62-and-impeding-ncomms8951-s9.ogv 6.0 s, 512 × 512; 250 KB
Tyrosine-kinase-inhibition-results-in-EGFR-clustering-at-focal-adhesions-and-consequent-exocytosis-1476-4598-7-47-S1.ogv 6.8 s, 320 × 240; 131 KB
Tyrosine-kinase-inhibition-results-in-EGFR-clustering-at-focal-adhesions-and-consequent-exocytosis-1476-4598-7-47-S2.ogv 12 s, 320 × 240; 431 KB
Tyrosine-kinase-inhibition-results-in-EGFR-clustering-at-focal-adhesions-and-consequent-exocytosis-1476-4598-7-47-S3.ogv 21 s, 320 × 240; 215 KB
Video-Rate-Bioluminescence-Imaging-of-Matrix-Metalloproteinase-2-Secreted-from-a-Migrating-Cell-pone.0025243.s001.ogv 1 min 15 s, 216 × 211; 505 KB
Video-Rate-Bioluminescence-Imaging-of-Matrix-Metalloproteinase-2-Secreted-from-a-Migrating-Cell-pone.0025243.s002.ogv 15 s, 216 × 211; 272 KB
Video-Rate-Bioluminescence-Imaging-of-Matrix-Metalloproteinase-2-Secreted-from-a-Migrating-Cell-pone.0025243.s003.ogv 4.7 s, 216 × 211; 250 KB
Video-Rate-Bioluminescence-Imaging-of-Matrix-Metalloproteinase-2-Secreted-from-a-Migrating-Cell-pone.0025243.s004.ogv 1 min 17 s, 210 × 195; 204 KB
Video-Rate-Bioluminescence-Imaging-of-Matrix-Metalloproteinase-2-Secreted-from-a-Migrating-Cell-pone.0025243.s005.ogv 1 min 40 s, 256 × 240; 283 KB
Widespread-Expression-of-BORISCTCFL-in-Normal-and-Cancer-Cells-pone.0022399.s008.ogv 20 s, 1,408 × 788; 1.35 MB
Widespread-Expression-of-BORISCTCFL-in-Normal-and-Cancer-Cells-pone.0022399.s009.ogv 20 s, 1,408 × 788; 4.88 MB
Widespread-Expression-of-BORISCTCFL-in-Normal-and-Cancer-Cells-pone.0022399.s010.ogv 20 s, 1,544 × 788; 909 KB
Widespread-Expression-of-BORISCTCFL-in-Normal-and-Cancer-Cells-pone.0022399.s011.ogv 20 s, 1,568 × 788; 5.61 MB